Citigroup Inc (C), Wells Fargo & Co (WFC): Banking on Banks

Page 1 of 2

Citigroup Inc (NYSE:C)Several big banks have reported earnings over the past week and it has helped push stocks back up to record highs. Citigroup Inc (NYSE:C) reported earnings on Monday that beat expectations and helped counterbalance tepid consumer spending numbers (which was up only 0.15% for core sales).

Citigroup Inc (NYSE:C) posted earnings of $1.25 a share ($3.89 billion), which beat expectations of $1.17 a share and was up from $1 a share ($3.08 billion) last year. Revenue from fixed income markets was up 18% and up a whopping 68% for equity markets. Citigroup Inc (NYSE:C)’s profits were up 26% year over year as loan losses narrowed. Another plus is that Citigroup Inc (NYSE:C)’s Basel III Tier 1 capital ratio rose to 10% from 9.3%.

Unlike Wells Fargo & Co (NYSE:WFC), which saw its revenue rise from $21.3 to $21.4 billion in its latest quarter, Citigroup Inc (NYSE:C) saw some strong top line growth. For Citigroup Inc (NYSE:C)’s latest quarter, revenue was up 12% year over year to $20.48 billion. In the quarter before, Citigroup posted a 30% increase in profit and a 3% increase in revenue.

Overseas

Citigroup is focusing more on its overseas operations and makes over 50% of its profits overseas. North America made Citigroup $2.13 billion in its latest quarter followed by Asia at $1.07 billion, Europe, the Middle East, and Africa at $1.04 billion, and Latin America at $900 million.

Citigroup saw huge gains in Europe, the Middle East, and Africa, with income rising by 51% year over year. In Latin America, Citigroup saw an 8.7% increase in profits and in Asia, a 10% increase. The new CEO of Citigroup who replaced Vikram Pandit, Michael Corbat, has said he wants to continue the push into emerging markets.

Value

Corbat wants to cut costs by $900 million in 2013 and increase that to $1.3 billion in 2014. Part of that is being done by cutting 11,000 jobs that Citigroup doesn’t see as vital. Another part is by eventually reducing legal costs associated with the financial crisis.

Citigroup trades at a PE of 16.3 and at 0.83 times book value. With a long term growth estimated at 15%, cost cutting efforts boosting margins, and a push into emerging markets, Citigroup could easily trade at book value. That implies 20% upside from these levels, which seems easily doable.

Gold in that mans Sachs?

Probably not, as Goldman Sachs Group Inc (NYSE:GS) fell 1.7% after reporting earnings and revenue that both beat estimates. Goldman Sachs Group Inc (NYSE:GS) posted earnings of $3.70 a share ($1.93 billion), up sharply from $962 million last year. That is an increase of just over 100%. On the revenue side, Goldman saw a 30% jump in revenue to $8.61 billion.

This wasn’t enough to impress Wall Street, which sent Goldman shares down a tad. Investors are worried that rising interest rates and increased levels of regulations are going to slow down Goldman’s growth. As rates rise the value of Goldman’s bond holdings fall and clients are less likely to jump in as they could wait and get a higher yield.

Goldman has a PE (trailing twelve months) of 9.75 and trades at a slight premium to book of 1.10. With EPS growth expected to be around 6% over the next few years, Goldman seems fairly valued at these levels. Goldman used to trade at a fat premium to other banks because of its aggressive capital allocation plans, but with a return on equity of 10.5% Goldman is still clearly in defensive mode. For this reason, it won’t be able to perform like it did before the financial crisis.

Goldman pays out a 1.2% dividend with a low payout ratio of 11.35%. Maybe in the future Goldman will be able to boost its dividend, but other than that Goldman Sachs has a fair amount of headwinds to deal with. With Dodd-Frank around the corner and uncertainty with QE, I wouldn’t recommend buying Goldman Sachs shares at this time.

Wells Fargo

Wells Fargo & Co (NYSE:WFC) was another bank to beat earnings, posting EPS of $0.98, which beat expectations by $0.05 per share and was up 20% year over year. Revenue was a slight beat as well, coming in at $21.4 billion, which is slightly higher than the $21.3 billion posted last year. The fact the revenue grew instead of contracting as expected definitely pleased Wall Street.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!